Royal Sense Ltd (ROYAL) — shareholding pattern, promoter holding, financials and share price

About Royal Sense Ltd (ROYAL)

Royal Sense Ltd operates in the Medical Equipment & Supplies industry, within the Healthcare sector. It trades on the NSE as ROYAL and on the BSE under scrip code 544143. Its ISIN is INE0QQG01019.

Incorporated in 2023, Royal Sense Ltd specializes in medical device and pharmaceutical trading. [1]

Royal Sense Limited supplies high-quality goods for hospitals, laboratories, and clinics, offering a broad range of products including surgical accessories, medical equipment, and pharmaceuticals.

Originally a group of sole proprietorships, Royal Sense was incorporated as a Public Limited Company in April 2023, consolidating its existing business under a new corporate structure.

Listed peers in Medical Equipment & Supplies: Aakaar Medical Technologies Ltd, Shree Pacetronix Ltd, KMS Medisurgi Ltd, Amkay Products Ltd, GKB Ophthalmics Ltd, Centenial Surgical Suture Ltd.

Valuation & Returns

10 Jul 2026

At ₹119.9 a share on 10 Jul 2026, Royal Sense Ltd (ROYAL) was valued at a price-to-earnings ratio of 8.92x against an industry P/E of 44.11x and a price-to-book of 1.68x on a book value of ₹71.06 per share. Solomo computes return on equity of 17.67% and return on capital employed of 20.31% from filed results.

P/E
8.92x
Industry P/E
44.11x
P/B
1.68x
EPS (TTM)
₹11.83
Book value / share
₹71.06
ROE
17.67%
ROCE
20.31%
ROA
11.72%
Debt / equity
0.32x
Dividend yield
0%
EBITDA margin
10.71%
52-week range
₹85 – ₹309.75

Ratios are computed from filed results and the last recorded price. Not investment advice.

Financial Performance

Mar 2026

In the year ended Mar 2026, Royal Sense Ltd (ROYAL) reported revenue of ₹103 crore, net profit of ₹7 crore and earnings per share of ₹13.36. That compares with revenue of ₹62 crore and net profit of ₹6 crore in Mar 2025. Figures are consolidated, as filed with the exchanges.

In the quarter ended Mar 2026, revenue was ₹60 crore and net profit ₹3 crore (consolidated).

Consolidated annual results for Royal Sense Ltd (ROYAL), Mar 2024 to Mar 2026. Revenue and net profit in ₹ crore; EPS in ₹ per share.
MetricMar 2024Mar 2025Mar 2026
Revenue (₹ cr)1862103
Net profit (₹ cr)267
EPS (₹)3.2412.7413.36
Compound annual growth for Royal Sense Ltd (ROYAL). Stock price CAGR is price return and excludes dividends.
Measure1Y
Sales growth246.80%
Profit growth298.11%
Stock price CAGR-44%

Ownership Summary

Mar 2026

As of Mar 2026, promoters hold 62.24% of Royal Sense Ltd (ROYAL). Market capitalisation was ₹64 crore on 10 Jul 2026. Shareholding is filed quarterly with BSE and NSE; Solomo carries every filing back to Mar 2024.

Largest disclosed public shareholders in Mar 2026: HUF 3.64%, HBPA TRADEX PRIVATE LIMITED 1.87%, MANISH KUMAR (HUF) 1.87%, Mukesh Sharma 1.57%, Ajit Kumar 1.29%, RIKHAV SECURITIES LIMITED 1.04%. Only stakes above the 1% disclosure threshold are named in filings.

QuarterPromoterPledgedFIIDIIPublic
Mar 202662.24%---37.76%
Sep 202562.24%---37.76%
Mar 202567.03%---32.97%
Sep 202467.96%---32.04%
Mar 202467.96%---32.04%
Every quarter since Mar 2024 Filing data, not investment advice.